143 0 Kommentare SuperSonic Imagine to Present Its Latest Innovations for the First Time at RSNA 2019 - Seite 2

“Liver diseases including non-alcoholic steatohepatitis (NASH) linked to conditions like diabetes and obesity affect millions of Americans and have become an important public health concern in the space of just a few years. We are very proud to present the fruits of our expertise in liver health — the series of three non-invasive liver markers — for the first time in the United States. All the more so as these markers have just received 510(k) clearance from the FDA. Following the acquisition of SuperSonic Imagine by Hologic, we are also going to present many shared sessions dedicated to women's health,” concludes Michèle Lesieur, the CEO of SuperSonic Imagine.

Demonstrations, workshops and sessions during RSNA 2019

A session entitled ‘Transformative Breast Ultrasound Technology’ led by Dr Stacy Smith-Foley (The Breast Center at CARTI, Little Rock, Arkansas) will take place on Monday, 2^nd December at 10:30 a.m., Hologic Workshop Room no. 5119, South Hall A, Level 3.

The Aixplorer MACH 30 and the latest addition to the product portfolio, the Aixplorer MACH 20, will be available at the SuperSonic Imagine booth no. 2324 (South Hall A). Furthermore, there will be live demonstrations throughout the conference.

For more information about SuperSonic Imagine products, visit http://www.aixplorer-mach.com/. For information about the company, visit http://www.supersonicimagine.com/

About SuperSonic Imagine

SuperSonic Imagine specializes in ultrasound medical imaging. The company manufactures the flagship Aixplorer series of products, which feature the company’s exclusive UltraFast technology. UltraFast has given rise to new imaging modes that set the standards of care for non-invasive characterization of breast, liver and prostate diseases. The first groundbreaking UltraFast mode developed is ShearWave Elastography (SWE), which enables doctors to view and instantly analyze tissue stiffness, a vitally important factor in the diagnosis of many conditions. To date, more than 600 published articles have validated the diagnostic value of SWE. The most recent addition to the Aixplorer range is the Aixplorer MACH 30 ultrasound platform that introduces the next generation of UltraFast imaging, which optimizes the system’s innovative imaging modes: ShearWave PLUS, Doppler UltraFast, Angio PL.U.S, TriVu and Needle PL.U.S. The company has more than 2,300 ultrasound systems installed in over 80 countries. Its main growth markets are China, the United States and the European Union (France). In 2018, the company generated a turnover of €24.6 million in 2018. SuperSonic Imagine is a company listed on Euronext (symbol: SSI).